Anti-CKIIα Antibody (13030)

$503.00

Host Quantity Applications Species Reactivity Data Sheet  
Rabbit 100ug WB,IP,IHC Human
SKU: 13030 Categories: , ,
Overview
Product Name Anti-CKIIα Antibody (13030)
Description Anti-CKIIα Rabbit Polyclonal Antibody
Target CKIIα
Species Reactivity Human
Applications WB,IP,IHC
Host Rabbit
Clonality Polyclonal
Isotype Whole IgG
Immunogen Synthetic peptide representing a portion of the protein located within exon 14 (LocusLink ID 1457).
Properties
Form Liquid
Concentration Lot Specific
Formulation Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09% Sodium Azide
Buffer Formulation Tris
Buffer pH pH 7.8
Buffer Anti-Microbial 0.1% Sodium Azide
Format Purified
Purification Purified by immunoaffinity chromatography
Specificity Information
Specificity This antibody reacts with human. Other species have not been tested. Antibody is affinity purified.
Target Name Casein kinase II subunitα
Target ID CKIIα
Uniprot ID P68400
Alternative Names CK IIα, EC 2.7.11.1
Gene Name CSNK2A1
Accession Number NP_001886.1
Sequence Location Nucleus
Biological Function Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine (PubMed:11239457, PubMed:11704824, PubMed:16193064, PubMed:19188443, PubMed:20625391, PubMed:22406621, PubMed:24962073). Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection (PubMed:12631575, PubMed:19387552, PubMed:19387551). May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response (PubMed:12631575, PubMed:19387552, PubMed:19387551). During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage (PubMed:11704824, PubMed:19188443). Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis (PubMed:11239457). Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3 (PubMed:16193064). Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8 (PubMed:16193064). Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, ATF4, SRF, MAX, JUN, FOS, MYC and MYB (PubMed:19387550, PubMed:12631575, PubMed:19387552, PubMed:19387551, PubMed:23123191). Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function (PubMed:19387550). Mediates sequential phosphorylation of FNIP1, promoting its gradual interaction with Hsp90, leading to activate both kinase and non-kinase client proteins of Hsp90 (PubMed:30699359). Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1 (PubMed:19387549). Acts as an ectokinase that phosphorylates several extracellular proteins (PubMed:19387550, PubMed:12631575, PubMed:19387552, PubMed:19387551). During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV (PubMed:19387550, PubMed:12631575, PubMed:19387552, PubMed:19387551). Phosphorylates PML at 'Ser-565' and primes it for ubiquitin-mediated degradation (PubMed:20625391, PubMed:22406621). Plays an important role in the circadian clock function by phosphorylating ARNTL/BMAL1 at 'Ser-90' which is pivotal for its interaction with CLOCK and which controls CLOCK nuclear entry (By similarity). Phosphorylates CCAR2 at 'Thr-454' in gastric carcinoma tissue (PubMed:24962073). {UniProtKB:P19139, PubMed:11239457, PubMed:11704824, PubMed:16193064, PubMed:19188443, PubMed:20625391, PubMed:22406621, PubMed:23123191, PubMed:24962073, PubMed:30699359, PubMed:12631575, PubMed:19387549, PubMed:19387550, PubMed:19387551, PubMed:19387552}.
Research Areas Enzymes
Application Images
Description Detection of human CKII Alpha by immunohistochemistry. Sample: FFPE section of human ovarian carcinoma. Antibody: Affinity purified rabbit anti-CKII Alpha (Cat. No. 13030 Lot2) used at a dilution of 1:5,000 (0.2µg/ml). Detection: DAB
Description Detection of human CKII alpha by western blot of immunoprecipitates. Samples: Whole cell lysate (1 mg for IP; 20% of IP loaded) from HeLa cells. Antibodies: Affinity purified rabbit anti-CKII alpha antibody 13030 (lot 13030-2) used for IP at 6 µg/mg lysate. CKII alpha was also immunoprecipitated by a previous lot (lot 13030-1) of this antibody. For blotting immunoprecipitated CKII alpha, 13030 was used at 1 µg/ml. Detection: Chemiluminescence with an exposure time of 3 seconds.
Description Detection of human and mouse CKII alpha by western blot. Samples: Whole cell lysate (50 µg) from HeLa, HEK293T, Jurkat, mouse TCMK-1, and mouse NIH 3T3 cells. Antibodies: Affinity purified rabbit anti-CKII alpha antibody 13030 (lot 13030-2) used for WB at 0.1 µg/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.
Additional Information
Handling
Storage Store at 2 - 8°C. Antibody is stable at 2 - 8°C for 1 year.
Dilution Instructions Dilute in PBS or medium which is identical to that used in the assay system.
Application Instructions

Immunoprecipitation: 4 -10 ug/mg lysate.
References & Data Sheet